1.成都市第七人民医院,四川省成都市双流区双兴大道1188号,610000
2.成都中医药大学附属医院
通信作者:277694022@qq.com
收稿:2025-07-17,
修回:2025-11-29,
纸质出版:2026-02-17
移动端阅览
王姣姣,韩林,周鹏程.呼吸吐纳操在慢性阻塞性肺疾病急性加重期患者早期肺康复中的效果评价[J].中医杂志,2026,67(04):432-438.
WANG Jiaojiao,HAN Lin,ZHOU Pengcheng.Effectiveness Evaluation of Exhalation-Inhalation Exercise on Early Pulmonary Rehabilitation for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Traditional Chinese Medicine,2026,67(04):432-438.
王姣姣,韩林,周鹏程.呼吸吐纳操在慢性阻塞性肺疾病急性加重期患者早期肺康复中的效果评价[J].中医杂志,2026,67(04):432-438. DOI: 10.13288/j.11-2166/r.2026.04.015.
WANG Jiaojiao,HAN Lin,ZHOU Pengcheng.Effectiveness Evaluation of Exhalation-Inhalation Exercise on Early Pulmonary Rehabilitation for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Traditional Chinese Medicine,2026,67(04):432-438. DOI: 10.13288/j.11-2166/r.2026.04.015.
目的
2
评价呼吸吐纳操在慢性阻塞性肺疾病(COPD)急性加重期患者早期肺康复中的作用。
方法
2
将120例COPD急性加重期患者随机分为治疗组及对照组各60例。对照组给予常规西药治疗,治疗组在常规西药基础上加呼吸吐纳操锻炼,每次训练30 min,每周5次。两组疗程均为12周。主要疗效指标为6分钟步行距离(6MWD),次要疗效指标包括肺功能指标[第一秒用力呼吸容积/用力肺活量(FEV1/FVC)、第一秒用力呼吸容积占预计值的百分比(FEV1%)、用力肺活量占预计值百分比(FVC%)]、圣乔治呼吸问卷(SGRQ)评分、改良医学研究委员会呼吸困难量表(mMRC)评分、慢性阻塞性肺疾病评估测试(CAT)评分、医院焦虑抑郁量表焦虑亚量表[HADS(A)]评分、医院焦虑抑郁量表抑郁亚量表[HADS(D)]评分,同时进行安全性评估。
结果
2
在治疗过程中,治疗组和对照组各脱落12例,最终两组各48例纳入分析。两组患者治疗后6MWD均高于本组治疗前,且治疗后治疗组6MWD高于对照组(
P
<0.05或
P
<0.01)。治疗组治疗后SGRQ评分、mMRC评分、CAT评分均低于本组治疗前,FEV1%、FVC%、FEV1/FVC均高于治疗前(
P
<0.05),且治疗后治疗组FEV1/FVC均高于对照组,SGRQ评分、mMRC评分、CAT评分均低于对照组(
P
<0.05或
P
<0.01)。对照组治疗前后肺功能指标及SGRQ评分、mMRC评分、CAT评分差异均无统计学意义(
P
>0.05)。两组治疗前后HADS(A)评分、HADS(D)评分差异均无统计学意义(
P
>0.05)。治疗组不良反应发生率为6.25%(3/48),对照组为0,两组比较差异无统计学意义(
P
>0.05)。
结论
2
在COPD急性期患者早期肺康复中进行呼吸吐纳操锻炼能提高患者的运动耐力、生活质量,改善临床症状及肺功能,且安全性好。
Objective
2
To evaluate the effectiveness of exhalation-inhalation exercise on early pulmonary rehabi-litation for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
Methods
2
A total of 120 participants with AECOPD were randomly divided into a treatment group and a control group, with 60 participants in each group. The control group treated with conventional western medicine, while the treatment group received exhalation-inhalation exercise training on the basis of conventional western medicine treatment, with 30 minutes per session and 5 sessions per week. The course of treatment for both groups was 12 weeks. The primary outcome was the 6-minute walking distance (6MWD). The secondary outcomes included pulmonary function indexes including forced expiratory volume in one second/forced vital capacity (FEV1/FVC), percentage of predicted forced expiratory volume in one second (FEV1%) and percentage of predicted forced vital capacity (FVC%), St.George's Respiratory Questionnaire (SGRQ) score, modified Medical Research Council (mMRC) dyspnea scale score, COPD assessment test (CAT) score, hospital anxiety and depression scale-anxiety subscale [HADS(A)] score, and hospital anxiety and depression scale-depression subscale [HADS(D)] score. Meanwhile, safety of all participants was recorded and assessed.
Results
2
During the treatment, 12 participants dropped out from both the treatment group and the control group, with 48 participants in each group finally included in the analysis. The 6MWD of both groups after treatment was higher than that before treatment, and the 6MWD of the treatment group was higher than that of the control group (
P
<0.05 or
P
<0.01). After treatment, the SGRQ score, mMRC score and CAT score of the treatment group were lower than those before treatment, while FEV1%, FVC% and FEV1/FVC were higher than those before treatment (
P
<0.05). Moreover, after treatment, the FEV1/FVC of the treatment group was higher than that of the control group, while the SGRQ score, mMRC score and CAT score were lower than those of the control group (
P
<0.05 or
P
<0.01). There was no statistically significant difference in pulmonary function indexes, SGRQ score, mMRC score and CAT score after treatment in the control group (
P
>0.05). No statistically significant difference was observed in HADS(A) score and HADS(D) score after treatment within and between groups (
P
>0.05). The incidence of adverse reactions in the treatment group was 6.25% (3/48), and 0 in the control group, with no statistically significant difference between groups (
P
>0.05).
Conclusion
2
Exhalation-inhalation exercise for patients with AECOPD in early pulmonary rehabilitation can improve patients' exercise tole-rance, quality of life, clinical symptoms and pulmonary function, with good safety.
WANG C , XU J , YANG L , et al . Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study [J]. Lancet , 2018 , 391 ( 10131 ): 1706 - 1717 .
FIORENTINO G , ESQUINAS AM , ANNUNZIATA A . Exercise and chronic obstructive pulmonary disease (COPD) [J]. Adv Exp Med Biol , 2020 , 1228 : 355 - 368 . doi: 10.1007/978-981-15-1792-1_24 http://dx.doi.org/10.1007/978-981-15-1792-1_24 .
ZHANG Q , LI S , ZHOU W , et al . Risk of pneumonia with different inhaled corticosteroids in COPD patients: a meta-analysis [J]. COPD , 2020 , 17 ( 4 ): 462 - 469 .
王晓娟 , 方向阳 . 慢性阻塞性肺疾病全球倡议2019:慢性阻塞性肺疾病诊断、治疗与预防全球策略解读 [J]. 中国全科医学 , 2019 , 22 ( 18 ): 2141 - 2149 .
ROCHESTER CL , ALISON JA , CARLIN B , et al . Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline [J]. Am J Respir Crit Care Med , 2023 , 208 ( 4 ): e7 - e26 .
中华人民共和国卫生部 . 慢性阻塞性肺疾病诊断标准 [J]. 国际呼吸杂志 , 2011 , 31 ( 1 ): 1 - 2 .
VENKATESAN P . GOLD COPD report: 2026 update [J]. Lancet Respir Med , 2025 , 26 : S2213-2600(25)00432 - 1 . doi: 10.1016/S2213-2600(25)00432-1 http://dx.doi.org/10.1016/S2213-2600(25)00432-1 .
CHAN AW , LEE A , LEE DT , et al . The sustaining effects of Tai chi Qigong on physiological health for COPD patients: a randomized controlled trial [J]. Complement Ther Med , 2013 , 21 ( 6 ): 585 - 594 .
蔡柏蔷 . 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案) [J]. 中华哮喘杂志 (电子版), 2013 , 7 ( 1 ): 1 - 13 .
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six-minute walk test [J]. Am J Respir Crit Care Med , 2002 , 166 ( 1 ): 111 - 117 .
JONES PW , QUIRK FH , BAVEYSTOCK CM . The St George's respiratory questionnaire [J]. Respiratory medicine , 1991 , 85 ( Suppl B ): 25 - 31 .
JONES PW , HARDING G , BERRY P , et al . Development and first validation of the COPD assessment test [J]. Eur Respir J , 2009 , 34 ( 3 ): 648 - 654 .
王蕾 , 杨汀 , 王辰 . 2017年版慢性阻塞性肺疾病诊断、处理和预防全球策略解读 [J]. 中国临床医生杂志 , 2017 , 45 ( 1 ): 104 - 108 .
JOHNSTON M , POLLARD B , HENNESSEY P . Construct validation of the hospital anxiety and depression scale with clinical populations [J]. J Psychosom Res , 2000 , 48 ( 6 ): 579 - 584 .
CLINI EM , CRISAFULLI E , COSTI S , et al . Effects of early inpatient rehabilitation after acute exacerbation of COPD [J]. Respir Med , 2009 , 103 ( 10 ): 1526 - 1531 .
吴浩 , 孙兴国 , 顾文超 , 等 . 功率自行车下肢亚极量运动对慢性阻塞性肺疾病康复影响的临床报告 [J]. 中国应用生理学杂志 , 2015 , 31 ( 4 ): 382 - 384 .
贾健玮 , 励志健 , 贾佩妮 . 体外膈肌起搏器对慢性阻塞性肺疾病急性加重期患者呼吸困难症状和生活质量的影响 [J]. 全科医学临床与教育 , 2019 , 17 ( 12 ): 1127 - 1129 .
李娜 , 赵水平 , 张艳莎 , 等 . 呼吸训练器辅助康复训练在慢阻肺稳定期患者中的应用价值 [J]. 中国康复 , 2024 , 39 ( 11 ): 682 - 685 .
向晋 , 江宇 . 弹力带抗阻运动对慢性阻塞性肺疾病患者肺康复效果评价 [J]. 现代医药卫生 , 2019 , 35 ( 10 ): 1553 - 1555 .
倪平 , 董桂英 , 吴小玲 . 中国传统锻炼应用于慢性阻塞性肺疾病患者肺康复的研究进展 [J]. 广西医学 , 2018 , 40 ( 19 ): 2332 - 2334 .
严鑫 , 郭秀君 , 孙敏芝 , 等 . 传统健身气功对慢性阻塞性肺疾病稳定期病人研究进展 [J]. 辽宁中医药大学学报 , 2014 , 16 ( 8 ): 157 - 159 .
刘荷英 , 李彩平 , 李春芳 , 等 . 呼吸训练在慢性阻塞性肺疾病患者恢复期的作用探讨 [J]. 基层医学论坛 , 2018 , 22 ( 21 ): 2902 - 2903 .
谭会领 . 长期腹式呼吸训练对慢性阻塞性肺疾病康复期患者的干预效果观察 [J]. 临床合理用药杂志 , 2016 , 9 ( 17 ): 94 - 95 .
李家晗 . 八段锦的历史源流与养生原理研究 [D]. 北京 : 中国中医科学院 , 2019 .
黄玉兰 , 冯林焰 , 林丹瑜 . 穴位按摩法对稳定期肺脾气虚COPD患者肺康复效果的临床观察 [J]. 医药前沿 , 2018 , 8 ( 3 ): 344 - 345 .
来薛 , 李珊 , 吴蔚 , 等 . 早期运用吐纳联合推拿康复方案对慢性阻塞性肺疾病急性加重期重度患者运动耐力及生活质量的影响 [J]. 中医杂志 , 2021 , 62 ( 22 ): 1984 - 1987,1995 .
潘怡 , 王振兴 , 闵婕 , 等 . 24式简化太极拳在慢性阻塞性肺疾病稳定期肺康复中的疗效评价 [J]. 中国康复医学杂志 , 2018 , 33 ( 6 ): 681 - 686 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号